Applications of polymer-based nanoparticles in vaccine field

Abstract Polymer-based nanoparticles have good solubility, stability, safety, and sustained release,which increases the absorption of loaded drugs, protects the drugs from degradation, and prolongs their circulation time and targeted delivery. Generally, we believe that prevention and control of infectious diseases through inoculation is the most efficient measure. However, these vaccines including live attenuated vaccines, inactivated vaccines, protein subunit vaccines, recombinant subunit vaccines, synthetic peptide vaccines and DNA vaccines have several defects, such as immune tolerance, poor immunogenicity, low expression level and induction of respiration pathological changes. All kinds of biodegradable natural and synthetic polymers play major roles in the vaccine delivery system to control the release of antigens for an extended period of time. In addition, these polymers also serve as adjuvants to enhance the immunogenicity of vaccine. This review mainly introduces natural and synthetic polymer-based nanoparticles and their formulation and properties. Moreover, polymer-based nanoparticles as adjuvants and delivery carriers in the applications of vaccine are also discussed. This review provides the basis for further operation of nano vaccines by utilizing the polymer-based nanoparticles as vaccine adjuvants and delivery systems. Polymer-based nanoparticles have exhibited great potential in improving the immunogenicity of antigens and the development of nano vaccines in future.

[1]  G. Sahoo,et al.  Study the effects of PLGA-PEG encapsulated Amphotericin B nanoparticle drug delivery system against Leishmania donovani , 2015, Drug delivery.

[2]  V. Labhasetwar,et al.  Biodegradable nanoparticles for cytosolic delivery of therapeutics. , 2007, Advanced drug delivery reviews.

[3]  Nikolai Petrovsky,et al.  Carbohydrate-based immune adjuvants , 2011, Expert review of vaccines.

[4]  N. Sahiner,et al.  Hyaluronic acid hydrogel particles with tunable charges as potential drug delivery devices , 2011 .

[5]  Claudia Felser,et al.  Exchange bias up to room temperature in antiferromagnetic hexagonal Mn3Ge , 2013, 1311.3067.

[6]  Xiaohua Wang,et al.  Enhancing Mucosal Immune Response of Newcastle Disease Virus DNA Vaccine Using N-2-Hydroxypropyl Trimethylammonium Chloride Chitosan and N,O-Carboxymethyl Chitosan Nanoparticles as Delivery Carrier. , 2018, Molecular pharmaceutics.

[7]  S. Gu,et al.  Thiolated trimethyl chitosan nanocomplexes as gene carriers with high in vitro and in vivo transfection efficiency. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[8]  Jui-Yi Chen,et al.  Nanoparticle Vaccines Adopting Virus-like Features for Enhanced Immune Potentiation , 2017, Nanotheranostics.

[9]  Di GiacomoSebastián,et al.  Use of Adjuvants to Enhance the Immune Response Induced by a DNA Vaccine Against Bovine Herpesvirus-1. , 2015 .

[10]  V. Dixit,et al.  Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza. , 2011, Vaccine.

[11]  Maria Angela Vandelli,et al.  In vitro evaluation of PLA nanoparticles containing a lipophilic drug in water-soluble or insoluble form. , 2004, International journal of pharmaceutics.

[12]  A. Vila,et al.  Design of biodegradable particles for protein delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Roger Le Grand,et al.  Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[14]  B. Verrier,et al.  Biodegradable Polymeric Nanoparticles-Based Vaccine Adjuvants for Lymph Nodes Targeting , 2016, Vaccines.

[15]  Yumin Yang,et al.  RGD-peptide conjugated inulin-ibuprofen nanoparticles for targeted delivery of Epirubicin. , 2016, Colloids and surfaces. B, Biointerfaces.

[16]  O. Abián,et al.  Cationic poly(ester amide) dendrimers: alluring materials for biomedical applications. , 2018, Journal of materials chemistry. B.

[17]  Yanhua Zhang,et al.  In vitro degradation and release profiles of poly-DL-lactide-poly(ethylene glycol) microspheres with entrapped proteins , 2000 .

[18]  R. Jarman,et al.  A novel dengue virus serotype-2 nanovaccine induces robust humoral and cell-mediated immunity in mice. , 2015, Vaccine.

[19]  G. Mogoșanu,et al.  Polymeric protective agents for nanoparticles in drug delivery and targeting. , 2016, International journal of pharmaceutics.

[20]  M. S. Singh,et al.  Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines. , 1998, Advanced drug delivery reviews.

[21]  Ting Huang,et al.  Chitosan-DNA nanoparticles enhanced the immunogenicity of multivalent DNA vaccination on mice against Trueperella pyogenes infection , 2018, Journal of Nanobiotechnology.

[22]  P. Diwan,et al.  Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles. , 2006, Die Pharmazie.

[23]  A. Florence,et al.  Release of DNA from dendriplexes encapsulated in PLGA nanoparticles. , 2005, International journal of pharmaceutics.

[24]  Lorne A. Babiuk,et al.  Approaches to Enhance the Efficacy of DNA Vaccines , 2004, Critical reviews in clinical laboratory sciences.

[25]  Shweta Sharma,et al.  PLGA-based nanoparticles: A new paradigm in biomedical applications , 2016 .

[26]  Carina I. C. Crucho,et al.  Polymeric nanoparticles: A study on the preparation variables and characterization methods. , 2017, Materials science & engineering. C, Materials for biological applications.

[27]  N. Mishra,et al.  PEG-PLA-PEG block copolymeric nanoparticles for oral immunization against hepatitis B. , 2010, International journal of pharmaceutics.

[28]  L. D'ilario,et al.  Amino-functionalized poly(l-lactide) lamellar single crystals as a valuable substrate for delivery of HPV16-E7 tumor antigen in vaccine development , 2015, International journal of nanomedicine.

[29]  S. Snigdha,et al.  Novel core-shell dextran hybrid nanosystem for anti-viral drug delivery. , 2018, Materials science & engineering. C, Materials for biological applications.

[30]  I. Oh,et al.  Physicochemical characterization of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide) nanoparticles with polyethylenimine as gene delivery carrier. , 2005, International journal of pharmaceutics.

[31]  G. Hays,et al.  Identification of genetically and oceanographically distinct blooms of jellyfish , 2013, Journal of The Royal Society Interface.

[32]  R. E. Morsi,et al.  Preparation and immunological evaluation of inactivated avian influenza virus vaccine encapsulated in chitosan nanoparticles. , 2017, Biologicals : journal of the International Association of Biological Standardization.

[33]  J. Carlos,et al.  Evaluación de la eficacia de formulaciones de anfotericina B encapsulada en micelas poliméricas como opción terapéutica en un modelo de Candidiasis en larvas de Galleria mellonella. , 2020 .

[34]  Khalid Saeed,et al.  Nanoparticles: Properties, applications and toxicities , 2017, Arabian Journal of Chemistry.

[35]  Yue Zhang,et al.  Nanoparticle-based local antimicrobial drug delivery. , 2017, Advanced drug delivery reviews.

[36]  E. Reverchon,et al.  Supercritical fluids applications in nanomedicine , 2015 .

[37]  W. Hennink,et al.  Covalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccination. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[38]  Yangchao Luo,et al.  Biocompatible polymeric nanoparticles with exceptional gastrointestinal stability as oral delivery vehicles for lipophilic bioactives , 2019, Food Hydrocolloids.

[39]  Kurt E. Geckeler,et al.  Polymer nanoparticles: Preparation techniques and size-control parameters , 2011 .

[40]  M. Díaz,et al.  Production and characterisation of biodegradable PLA nanoparticles loaded with thymol to improve its antimicrobial effect , 2018, Journal of Food Engineering.

[41]  Q. Pankhurst,et al.  Application of magnetic field hyperthermia and superparamagnetic iron oxide nanoparticles to HIV-1-specific T-cell cytotoxicity , 2013, International journal of nanomedicine.

[42]  S. Vyas,et al.  Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. , 2006, Vaccine.

[43]  K. Kataoka,et al.  Intraperitoneal Administration of a Tumor-Associated Antigen SART3, CD40L, and GM-CSF Gene-Loaded Polyplex Micelle Elicits a Vaccine Effect in Mouse Tumor Models , 2014, PloS one.

[44]  D. Betbeder,et al.  Nasal nanovaccines. , 2017, International journal of pharmaceutics.

[45]  J. Nah,et al.  Preparation of poly(DL‐lactide‐co‐glycolide) nanoparticles without surfactant , 2001 .

[46]  R. Bhatnagar,et al.  Single-dose Ag85B-ESAT6–loaded poly(lactic-co-glycolic acid) nanoparticles confer protective immunity against tuberculosis , 2019, International journal of nanomedicine.

[47]  T. Kissel,et al.  Characterization of a homologous series of D,L-lactic acid oligomers; a mechanistic study on the degradation kinetics in vitro. , 2003, Biomaterials.

[48]  V. Préat,et al.  PLGA-based nanoparticles: an overview of biomedical applications. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[49]  G. Mutwiri TLR9 agonists: immune mechanisms and therapeutic potential in domestic animals. , 2012, Veterinary immunology and immunopathology.

[50]  J. Talmadge,et al.  The pharmaceutics and delivery of therapeutic polypeptides and proteins , 1993 .

[51]  G. Borchard,et al.  Immune response elicited by an intranasally delivered HBsAg low-dose adsorbed to poly-ε-caprolactone based nanoparticles. , 2016, International journal of pharmaceutics.

[52]  Jing Liu,et al.  Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy. , 2018, International journal of pharmaceutics.

[53]  Raimar Löbenberg,et al.  Overview of the preparation of organic polymeric nanoparticles for drug delivery based on gelatine, chitosan, poly(d,l-lactide-co-glycolic acid) and polyalkylcyanoacrylate. , 2014, Colloids and surfaces. B, Biointerfaces.

[54]  M. Akashi,et al.  [Development of polymeric nanoparticles-based vaccine]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.

[55]  Marc Schneider,et al.  Influence of different stabilizers on the encapsulation of desmopressin acetate into PLGA nanoparticles , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[56]  S. Caruthers,et al.  Molecular imaging and therapy of atherosclerosis with targeted nanoparticles , 2007, Journal of magnetic resonance imaging : JMRI.

[57]  M. Edirisinghe,et al.  Bioinspired preparation of alginate nanoparticles using microbubble bursting. , 2015, Materials science & engineering. C, Materials for biological applications.

[58]  C. Russell Middaugh,et al.  Nanotechnology in vaccine delivery☆ , 2008, Advanced Drug Delivery Reviews.

[59]  A. Oliveira,et al.  Development, characterization, antioxidant and hepatoprotective properties of poly(Ɛ-caprolactone) nanoparticles loaded with a neuroprotective fraction of Hypericum perforatum. , 2017, International journal of biological macromolecules.

[60]  F. Masood,et al.  Polymeric nanoparticles for targeted drug delivery system for cancer therapy. , 2016, Materials science & engineering. C, Materials for biological applications.

[61]  P. A. Shah,et al.  Natural biodegradable polymers based nano‐formulations for drug delivery: A review , 2019, International journal of pharmaceutics.

[62]  Gerrit Borchard,et al.  Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen. , 2008, International immunopharmacology.

[63]  Azra Yasmin,et al.  Microbial synthesis of nanoparticles and their potential applications in biomedicine , 2017 .

[64]  Deep Pooja,et al.  Inulin: A novel and stretchy polysaccharide tool for biomedical and nutritional applications. , 2019, International journal of biological macromolecules.

[65]  S. Broderick,et al.  Activation of innate immune responses in a pathogen-mimicking manner by amphiphilic polyanhydride nanoparticle adjuvants. , 2011, Biomaterials.

[66]  K. Kang,et al.  Entrapment of H1N1 Influenza Virus Derived Conserved Peptides in PLGA Nanoparticles Enhances T Cell Response and Vaccine Efficacy in Pigs , 2016, PloS one.

[67]  K. Johnston,et al.  Microencapsulation of proteins by rapid expansion of supercritical solution with a nonsolvent , 2000 .

[68]  Yumin Yang,et al.  Synthesis of methylprednisolone loaded ibuprofen modified inulin based nanoparticles and their application for drug delivery. , 2014, Materials science & engineering. C, Materials for biological applications.

[69]  Abolfazl Akbarzadeh,et al.  PLGA-based nanoparticles as cancer drug delivery systems. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[70]  V. Apostolopoulos,et al.  Poly-L-lysine-coated nanoparticles: a potent delivery system to enhance DNA vaccine efficacy. , 2007, Vaccine.

[71]  Kutty Selva Nandakumar,et al.  Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases , 2013, Journal of The Royal Society Interface.

[72]  Catarina Pinto Reis,et al.  Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. , 2006, Nanomedicine : nanotechnology, biology, and medicine.

[73]  Jian Zhang,et al.  Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection. , 2002, Human gene therapy.

[74]  U. Bakowsky,et al.  Preparation and characterization of chitosan and trimethyl-chitosanmodified poly-(ε-caprolactone) nanoparticles as DNA carriers , 2005, AAPS PharmSciTech.

[75]  Chun-Xia Zhao,et al.  Nanoparticle vaccines. , 2014, Vaccine.

[76]  K. Rostamizadeh,et al.  Efficiency of flubendazole-loaded mPEG-PCL nanoparticles: A promising formulation against the protoscoleces and cysts of Echinococcus granulosus. , 2018, Acta tropica.

[77]  Wei Sun,et al.  Chitosan-based formulations for delivery of DNA and siRNA. , 2010, Advanced drug delivery reviews.

[78]  Ya‐Ping Sun,et al.  Preparation of Nanoscale Semiconductors through the Rapid Expansion of Supercritical Solution (RESS) into Liquid Solution , 2000 .

[79]  A. Amaral,et al.  Is it possible to track intracellular chitosan nanoparticles using magnetic nanoparticles as contrast agent? , 2019, Bioorganic & medicinal chemistry.

[80]  Yanhang Hong,et al.  Polymers for DNA Vaccine Delivery. , 2017, ACS biomaterials science & engineering.

[81]  Y. Doki,et al.  Heteroclitic serological response in esophageal and prostate cancer patients after NY‐ESO‐1 protein vaccination , 2012, International journal of cancer.

[82]  Marco Alberto Javarone,et al.  Modeling Radicalization Phenomena in Heterogeneous Populations , 2015, PloS one.

[83]  M. Singh,et al.  A novel bioadhesive intranasal delivery system for inactivated influenza vaccines. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[84]  H. Kiyono,et al.  Nanogel-Based PspA Intranasal Vaccine Prevents Invasive Disease and Nasal Colonization by Streptococcus pneumoniae , 2013, Infection and Immunity.

[85]  E. Kolesanova,et al.  Synthetic peptide vaccines , 2010, Biomeditsinskaia khimiia.

[86]  C. Figdor,et al.  Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity. , 2011, Blood.

[87]  Olivier Rouaud,et al.  Microencapsulation by solvent evaporation: state of the art for process engineering approaches. , 2008, International journal of pharmaceutics.

[88]  A. Bolhassani,et al.  Physicochemical properties of polymers: An important system to overcome the cell barriers in gene transfection , 2015, Biopolymers.

[89]  H. Yadav,et al.  DIFFERENT TECHNIQUES FOR PREPARATION OF POLYMERIC NANOPARTICLES-A , 2012 .

[90]  S. Geary,et al.  Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses , 2013, Human vaccines & immunotherapeutics.

[92]  D. Clements,et al.  Preclinical development of a dengue tetravalent recombinant subunit vaccine: Immunogenicity and protective efficacy in nonhuman primates. , 2015, Vaccine.

[93]  F. Goycoolea,et al.  Self-assembled high molecular weight inulin nanoparticles: Enzymatic synthesis, physicochemical and biological properties. , 2019, Carbohydrate polymers.

[94]  Paulo José do Amaral Sobral,et al.  Formulation optimization of lecithin-enhanced pickering emulsions stabilized by chitosan nanoparticles for hesperidin encapsulation , 2017, Journal of Food Engineering.

[95]  Jinyan Sun,et al.  O-2'-hydroxypropyltrimethyl ammonium chloride chitosan nanoparticles for the delivery of live Newcastle disease vaccine. , 2015, Carbohydrate polymers.

[96]  Xiaoyong Fan,et al.  Intranasal Vaccination with Chitosan-DNA Nanoparticles Expressing Pneumococcal Surface Antigen A Protects Mice against Nasopharyngeal Colonization by Streptococcus pneumoniae , 2010, Clinical and Vaccine Immunology.

[97]  R. Bandopadhyay,et al.  Use of dextran nanoparticle: A paradigm shift in bacterial exopolysaccharide based biomedical applications. , 2016, International journal of biological macromolecules.

[98]  D. Doolan,et al.  Systematic evaluation of self-adjuvanting lipopeptide nano-vaccine platforms for the induction of potent CD8(+) T-cell responses. , 2016, Nanomedicine.

[99]  Kaili Hu,et al.  Chitosan and chitosan coating nanoparticles for the treatment of brain disease , 2019, International journal of pharmaceutics.

[100]  Y. Chevalier,et al.  Mechanism of nanocapsules formation by the emulsion-diffusion process. , 2008, Journal of colloid and interface science.

[101]  Decheng Wu,et al.  Biodegradable dendrimers for drug delivery. , 2018, Materials science & engineering. C, Materials for biological applications.

[102]  Zheng Jin,et al.  Antimicrobial activity and cytotoxicity of N-2-HACC and characterization of nanoparticles with N-2-HACC and CMC as a vaccine carrier , 2013 .

[103]  N. Ahmed,et al.  Recent applications of PLGA based nanostructures in drug delivery. , 2017, Colloids and surfaces. B, Biointerfaces.

[104]  Udita Agrawal,et al.  Polymer nanotechnology based approaches in mucosal vaccine delivery: challenges and opportunities. , 2015, Biotechnology advances.

[105]  Nick C Fox,et al.  Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease , 2014, PLoS ONE.

[106]  Tejraj M Aminabhavi,et al.  Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[107]  V. Quattrocchi,et al.  Use of Adjuvants to Enhance the Immune Response Induced by a DNA Vaccine Against Bovine Herpesvirus-1. , 2015, Viral immunology.

[108]  Xiaohua Wang,et al.  Response of live Newcastle disease virus encapsulated in N-2-hydroxypropyl dimethylethyl ammonium chloride chitosan nanoparticles. , 2017, Carbohydrate polymers.

[109]  W. Britton,et al.  Alginate modified-PLGA nanoparticles entrapping amikacin and moxifloxacin as a novel host-directed therapy for multidrug-resistant tuberculosis , 2019, Journal of Drug Delivery Science and Technology.

[110]  Y. Okahata,et al.  Mechanism of cell transfection with plasmid/chitosan complexes. , 2001, Biochimica et biophysica acta.

[111]  B. Narasimhan,et al.  Polyanhydride microparticles enhance dendritic cell antigen presentation and activation. , 2011, Acta biomaterialia.

[112]  A. Dehshahri,et al.  Plant virus nanoparticles: Novel and robust nanocarriers for drug delivery and imaging. , 2018, Colloids and surfaces. B, Biointerfaces.

[113]  Xiaohua Wang,et al.  Quaternized chitosan nanoparticles loaded with the combined attenuated live vaccine against Newcastle disease and infectious bronchitis elicit immune response in chicken after intranasal administration , 2017, Drug delivery.

[114]  D. Lewis,et al.  A cationic liposome-DNA complexes adjuvant (JVRS-100) enhances the immunogenicity and cross-protective efficacy of pre-pandemic influenza A (H5N1) vaccine in ferrets. , 2016, Virology.